Skip to main content
. 2021 Mar 15;104(5):1820–1829. doi: 10.4269/ajtmh.20-1481

Figure 3.

Figure 3.

Number of therapeutic efficacy reports by country, excluding multicountry studies (A). Frequency of excluding new infections from the final analyses (rather than including them as adequate clinical and parasitological responses [ACPR]) in the per-protocol analysis by country (B).